NHS
Giant Cell Arteritis — GCA Navigator
BSR 2020 Guideline
Guidance loading...
1 Clinical features
›
2 Clinical impression
›
3 Inflammatory markers if available
›
4 Guideline reference

Always consider alternative diagnoses

Herpes zoster Tension / cluster / migraine headache Trigeminal neuralgia Cervical spondylosis Acute angle closure glaucoma Retinal TIA / embolic visual deficits TMJ dysfunction Sinus / ear disease Intracranial pathology
Tick every feature present. Ordered by urgency.0 sight-threatening0 cranial0 systemic
Sight-threatening / ischaemicAny one of these raises concern for imminent sight loss.0 ticked
✓
Acute visual loss
Transient or permanent, one or both eyes
✓
Diplopia / double vision
New onset
✓
Jaw or tongue claudication
Pain on chewing — high specificity
✓
Visual disturbance
Blurring, field defect, amaurosis fugax
Cranial / vascularTypical cranial features of GCA.0 ticked
✓
New onset headache
Typically temporal
✓
Scalp tenderness
Including pain on brushing hair
✓
Temporal artery abnormal
Tender, thickened, reduced pulsation
✓
Neurological features
TIA, stroke, confusion
Systemic / PMR and contextSupporting features, and anything that changes how markers read.0 ticked
✓
PMR features
Shoulder/hip girdle stiffness
✓
Constitutional symptoms
Malaise, fever, weight loss
✓
Already on steroids context
Markers may be suppressed
2 Your clinical impression · tick one
Please reflect on this case, then tick the one option that most closely matches your clinical impression.

Weigh the features above with your history, examination and what you know of this patient. Your choice, not a score, decides which BSR 2020 guidance is shown next.

BSR 2020 treats GCA as strongly suspected when, in your judgement, it is more likely than any other explanation.

↓Features recorded. Now tick the option below that best matches your clinical impression.
3 Inflammatory markers — if available

⚠ Critical marker caveats

▶Normal ESR does not exclude GCA. Up to 15% of biopsy-proven GCA cases have a normal ESR — those patients carry equal risk of sight loss.
▶Normal CRP does not exclude GCA. ~10% of GCA patients have both normal ESR and normal CRP at diagnosis. CRP is the more sensitive single marker (~87% vs ~84%).
▶Plasma viscosity (PV) is the primary marker in NHS Grampian. PV and ESR each produce ~13% false negatives independently.
▶Steroids suppress markers rapidly. Normal markers must not downgrade suspicion if patient is on corticosteroids.
Plasma viscosity (cP) Normal <1.72 · Raised ≥1.72 · Significantly raised ≥1.90
CRP (mg/L) Normal <10 · Raised 10–49 · Significantly raised ≥50
ESR (mm/hr) Significantly raised ≥80 mm/hr · Normal does not exclude GCA
Steroid effect flagged: All markers may be suppressed. Normal results cannot downgrade suspicion.
All markers within normal range. This does not exclude GCA. Clinical features and judgement take precedence.
★ ★ ★ ★ ★
Select a star rating above to submit
✓ Thanks — feedback received